Literature DB >> 27193468

Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases.

Ayse Nur Tufan1, Saim Sag2, Mustafa Ferhat Oksuz3, Selime Ermurat3, Belkis Nihan Coskun3, Mustafa Gullulu4, Ferah Budak5, Ibrahim Baran6, Yavuz Pehlivan3, Ediz Dalkilic3.   

Abstract

Patients with connective tissue diseases (CTDs) may have prolonged corrected QT interval which indicates increased risk for ventricular arrhythmias. However, a more sensitive measure of ventricular repolarization, T-peak-to-end (Tpe) interval, has not been studied in CTDs. We aimed to investigate the relationship between ventricular repolarization abnormalities and anti-Ro52-positivity in subjects with connective tissue diseases (CTDs). We enrolled patients with anti-Ro52-positive CTDs, ANA-positive CTDs, and healthy subjects in this cross-sectional study. We excluded conditions potentially affecting the QT interval. We compared the ECG measures between the groups and performed analyses to define factors associated with ventricular repolarization measures. 15 ANA and anti-Ro52-positive, 39 ANA-positive and anti-Ro52-negative, and 22 healthy subjects were enrolled. None of the subjects had rhythm or conduction disturbances. Corrected QT intervals were similar between the groups. Tpe (84, 77.3, and 69.4 msn, respectively) and QT-dispersion (40, 27.2, and 20.1 msn, respectively) were higher in anti-Ro52-positive subjects compared with the ANA-positive and healthy subjects. Anti-Ro52 titers were correlated with Tpe and QT-dispersion (r = 0.52 and p < 0.001 for each). ANA and anti-Ro52-positivity were independently associated with higher Tpe (OR = 7.7, p = 0.001 and OR = 6.9, p = 0.001, respectively), corrected Tpe (OR = 11.3, p = 0.001 and OR = 8.4, p = 0.003, respectively), QT dispersion (OR = 7, p = 0.008 and OR = 13, p < 0.001, respectively), and QTc dispersion (OR = 9.1, p = 0.001 and OR = 14.1, p < 0.001, respectively). This study provides evidence that ANA positivity, especially when concomitant anti-Ro52-positivity is present, significantly deteriorates ventricular repolarization. The aforementioned ventricular repolarization abnormalities may render these subjects susceptible to serious rhythm or conduction disorders in the setting of predisposing conditions.

Entities:  

Keywords:  Anti-Ro52; Arrhythmia; Connective tissue disease; Tpeak-tend; Ventricular repolarization

Mesh:

Substances:

Year:  2016        PMID: 27193468     DOI: 10.1007/s00296-016-3488-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

Review 1.  Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implications.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Heart Rhythm       Date:  2014-10-29       Impact factor: 6.343

2.  Absence of conduction defects in the electrocardiograms [correction of echocardiograms] of mothers with children with congenital complete heart block.

Authors:  P A Gordon; E Rosenthal; M A Khamashta; G R Hughes
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

Review 3.  Molecular mechanisms of congenital heart block.

Authors:  Aurélie Ambrosi; Sven-Erik Sonesson; Marie Wahren-Herlenius
Journal:  Exp Cell Res       Date:  2014-01-13       Impact factor: 3.905

4.  Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk.

Authors:  Branislav Milovanović; Ljudmila Stojanović; Nebojsa Milićevik; Karin Vasić; Bojko Bjelaković; Mirjana Krotin
Journal:  Srp Arh Celok Lek       Date:  2010 Jan-Feb       Impact factor: 0.207

5.  Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis.

Authors:  Ahmed M Adlan; Vasileios F Panoulas; Jacqueline P Smith; James P Fisher; George D Kitas
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

6.  Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea.

Authors:  Fethi Kilicaslan; Alptug Tokatli; Fatih Ozdag; Mehmet Uzun; Omer Uz; Zafer Isilak; Omer Yiginer; Murat Yalcin; Mehmet Senol Guney; Bekir Sitki Cebeci
Journal:  Pacing Clin Electrophysiol       Date:  2012-06-05       Impact factor: 1.976

7.  Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Francesca Guideri; Francesca Bellisai; Enrico Selvi; Maurizio Acampa; Agnese Costa; Roberta Maggio; Estrella Garcia-Gonzalez; Stefania Bisogno; Gabriella Morozzi; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  Am J Cardiol       Date:  2007-07-06       Impact factor: 2.778

8.  Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.

Authors:  Nathalie Costedoat-Chalumeau; Zahir Amoura; Jean-Marc Lupoglazoff; Du Le Thi Huong; Isabelle Denjoy; Danièle Vauthier; Djamel Sebbouh; Olivier Fain; Sophie Georgin-Lavialle; Pascale Ghillani; Lucile Musset; Bertrand Wechsler; Pierre Duhaut; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2004-10

9.  Prolongation of heart rate-corrected QT interval is a predictor of cardiac autonomic dysfunction in patients with systemic lupus erythematosus.

Authors:  Atsushi Nomura; Mitsumasa Kishimoto; Osamu Takahashi; Gautam A Deshpande; Kenichi Yamaguchi; Masato Okada
Journal:  Rheumatol Int       Date:  2013-03-16       Impact factor: 2.631

10.  Corticosteroid treatment normalizes QTc prolongation and improves heart block in an elderly patient with anti-Ro-positive systemic lupus erythematosus.

Authors:  Maksat Saribayev; Fatih Tufan; Fahrettin Oz; Burak Erer; Tahsin Ozpolat; Gulistan Bahat Ozturk; Sibel Akin; Bulent Saka; Nilgun Erten; Cemil Tascioglu; Akif Karan
Journal:  Aging Clin Exp Res       Date:  2013-11-02       Impact factor: 3.636

View more
  5 in total

Review 1.  T-Wave Indices and Atherosclerosis.

Authors:  Gary Tse; George Bazoukis; Leonardo Roever; Tong Liu; William K K Wu; Martin C S Wong; Adrian Baranchuk; Panagiotis Korantzopoulos; Dimitrios Asvestas; Konstantinos P Letsas
Journal:  Curr Atheroscler Rep       Date:  2018-09-17       Impact factor: 5.113

2.  Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Lupus Sci Med       Date:  2016-12-08

Review 3.  Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Nabil El-Sherif; Franco Laghi-Pasini; Mohamed Boutjdir
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

Review 4.  Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias.

Authors:  Luigi X Cubeddu; Daisy de la Rosa; Michele Ameruoso
Journal:  Bioimpacts       Date:  2021-12-22

Review 5.  The Role of Autoantibodies in Arrhythmogenesis.

Authors:  Jin Li
Journal:  Curr Cardiol Rep       Date:  2020-11-25       Impact factor: 2.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.